Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) Report

Skin Cancer

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

J Clin Oncol

Rotz SJ, Stratton K, Leisenring WM, Smith SA, Howell RM, Bates JE, Pappo AS, Neglia JP, Armstrong GT, Turcotte LM

doi: 10.1200/JCO-24-01519

Further Publications

Risk Factors for Valvulopathy Among Childhood Cancer Survivors

JAMA Oncol

Aho Glele R, Feijen EAM, Fresneau B, Reulen RC, Allodji RS, Vu-Bezin G, Schwartz B, Journy N, Minard-Colin V, Bagnasco F, Bardi E, Belle FN, Byrne J, van Dalen EC, Teepen JC, Grabow D, Kaatsch P, Hjorth L, Jankovic M, Kuehni CE, Levitt G, Veres C, Aerts I, Zadravec Zaletel L, van der Pal HJH, Ronckers C, Sacerdote C, Skinner R, Jakab Z, Michel G, Terenziani M, Haddy N, Thierry-Chef I, Cardis E, Diallo I, Winter DL, Kremer LCM, Hawkins MM, de Vathaire F

doi: 10.1001/jamaoncol.2025.3863

SPECIAL REPORT

Breast Cancer

Advances in HER2-Negative Breast Cancer Treatment: Insights from the PRIMED study

Genitourinary Cancer

Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study

Eur Urol

Karpinski MJ, Rahbar K, Bögemann M, Nikoukar LR, Schäfers M, Hoberück S, Miederer M, Hölscher T, Rasul S, Miszczyk M, Lanfranchi F, Bauckneht M, Pfob CH, Kind F, Goffin K, Hüsing A, Kesch C, Herrmann K, Stuschke M, Gafita A, Hüsing J, Calais J, Hofman MS, Hope TA, Miksch J, Soeterik TFW, Di Giorgio A, Farolfi A, Bjartell A, Trägårdh E, Unterrainer LM, Holzgreve A, Sheikh GT, Rauscher I, Eiber M, Hadaschik BA, Fendler WP

doi: 10.1016/j.eururo.2025.04.017

Gastrointestinal Cancer

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE

Int J Cancer

Potthoff K, Uhlig J, Jacobasch L, Müller L, Reiser M, de Buhr R, Polata S, Gerger A, Zehrer V, Amann A, Göhler T, Serrer L, Schröder J, Semsek D, Köhler A, Stübs P, Prager G, Siebenbach HU, Schuch A, Marschner N

doi: 10.1002/ijc.70139

Lung, Respiratory and Thoracic Cancer

Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study

Lung Cancer

Tafur A, Sebai A, Shi Z, Wei J, Tran H, Zheng SL, Krantz S, Hensing T, Mansfield AS, Xu J

doi: 10.1016/j.lungcan.2025.108712

Gastrointestinal Cancer

Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study

Eur J Cancer

Yamamoto K, Bando H, Misumi T, Nishikawa T, Wakabayashi M, Yamazaki K, Maehara Y, Oki E, Saltz LB, Douillard JY, Punt CJ, Koopman M, Van Cutsem E, Bokemeyer C, Venook AP, Heinemann V, Cremolini C, Randolph Hecht J, Schmoll HJ, Nakayama G, Lenz HJ, Andre T, Shi Q, de Gramont A, Shitara K, Yoshino T

doi: 10.1016/j.ejca.2025.116034

Further Publications

Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group

J Clin Oncol

Kooijmans ECM, Mulder RL, Marks SD, Pavasovic V, Motwani SS, Walwyn T, Larkins NG, Kruseova J, Constine LS, Wallace WH, Green DM, Bökenkamp A, van der Pal HJH, van den Heuvel-Eibrink MM, Hjorth L, Andrés-Jensen L, Bardi E, van Dalen EC, Demoor-Goldschmidt C, Becktell K, Grönroos M, Kieran K, Mironova D, Terenziani M, Veening MA, Zieg J, Onder S, Onder AM, Routh JC, Thompson J, Hudson MM, Kremer LCM, Skinner R, Ehrhardt MJ

doi: 10.1200/JCO-24-02534